Edwards Lifesciences (EW) Stock Forecast & Price Target
Score
Edwards Lifesciences Corporation price target
| EW | |
|---|---|
| Low | $85.00 |
| Median | $101.00 |
| High | $113.00 |
| Upside vs current price | +1.6% |
The median target of $101.00 is +1.6% versus the current EW price of $99.37.
Edwards Lifesciences Corporation analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 5 |
| Buy | 19 |
| Hold | 7 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
31 analysts cover EW.
Edwards Lifesciences Corporation EPS and revenue estimates
EW shows the next fiscal years with at least three analysts: 2026 EPS $3.00, 2027 EPS $3.39. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $3.00 | $6.77B |
| 2027 | $3.39 | $7.44B |
Is Edwards Lifesciences Corporation a buy or sell?
Of the 31 analysts covering Edwards Lifesciences Corporation, 24 rate it a buy (5 strong buy and 19 buy), 7 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The EW consensus label is Buy, beside 24 buy-side ratings and 0 sell-side ratings.
The median target of $101.00 implies +1.6% versus the current price of $99.37.
Those 31 ratings on EW are a headcount, and the label on file is Buy.
Reading the Edwards Lifesciences Corporation forecast
The EW target band runs from $85.00 to $113.00. The median target inside that band is $101.00.
Set next to the $99.37 EW quote, that median is +1.6%.
Ratings on the Edwards Lifesciences Corporation cluster: 24 of 31 analysts are on the buy side, 7 are at hold, and 0 are on the sell side, and the published consensus is Buy.
Recent EW revisions are two-sided: 1 upgrades and 0 downgrades.
The EW average target is little changed, $108.50 over the last month and $108.50 over the last quarter.
15 firms published targets on EW, so one note does not swing the median by itself.
Edwards Lifesciences Corporation forecast questions
What is the EW price target?
The published range for EW is $85.00 to $113.00, with a median target of $101.00. That median is +1.6% versus the current price of $99.37.
Is Edwards Lifesciences Corporation a buy or sell?
Of the 31 analysts covering Edwards Lifesciences Corporation, 24 rate it a buy, 7 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the EW headcount is 24 buy, 7 hold, and 0 sell.
What is the EPS estimate for Edwards Lifesciences Corporation?
Analyst EPS estimates for Edwards Lifesciences Corporation: 2026 $3.00, 2027 $3.39.
What is the revenue estimate for Edwards Lifesciences Corporation?
Analyst revenue estimates for Edwards Lifesciences Corporation: 2026 $6.77B, 2027 $7.44B.
How many analysts cover EW?
31 analysts cover EW. Their consensus on EW is Buy, across those 31.